157 related articles for article (PubMed ID: 33474987)
1. Clinical Impact of FDG PET/CT of the Lower Extremities in Patients With Merkel Cell Carcinoma With Primary Disease Site Outside of the Lower Extremities.
Ishiyama M; Behnia F; Vesselle H
AJR Am J Roentgenol; 2021 Mar; 216(3):776-780. PubMed ID: 33474987
[No Abstract] [Full Text] [Related]
2. Lack of clinical impact of
Liu J; Larcos G; Howle J; Veness M
Australas J Dermatol; 2017 May; 58(2):99-105. PubMed ID: 26459330
[TBL] [Abstract][Full Text] [Related]
3. Merkel cell carcinoma: Is there a role for 2-deoxy-2-[f-18]fluoro-D-glucose-positron emission tomography/computed tomography?
Iagaru A; Quon A; McDougall IR; Gambhir SS
Mol Imaging Biol; 2006; 8(4):212-7. PubMed ID: 16724293
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of "true whole-body" (18)F-FDG PET/CT: lesion frequency and added benefit in distal lower extremities.
Kawata S; Imaizumi M; Kako Y; Oku N
Ann Nucl Med; 2014 May; 28(4):322-8. PubMed ID: 24488705
[TBL] [Abstract][Full Text] [Related]
5.
Mahajan S; Barker CA; Mauguen A; D'Angelo SP; Yeh R; Pandit-Taskar N
J Nucl Med; 2022 Jun; 63(6):906-911. PubMed ID: 34620729
[TBL] [Abstract][Full Text] [Related]
6. The impact of (18)F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: results from Westmead Hospital, Sydney, Australia.
Concannon R; Larcos GS; Veness M
J Am Acad Dermatol; 2010 Jan; 62(1):76-84. PubMed ID: 20082888
[TBL] [Abstract][Full Text] [Related]
7. Metabolic assessment of Merkel cell carcinoma: the role of 18F-FDG PET/CT.
Ben-Haim S; Garkaby J; Primashvili N; Goshen E; Shapira R; Davidson T; Israel O; Epelbaum R
Nucl Med Commun; 2016 Aug; 37(8):865-73. PubMed ID: 27092665
[TBL] [Abstract][Full Text] [Related]
8. The impact of (18)F-FDG-PET/CT on Merkel cell carcinoma management: a retrospective study of 66 scans from a single institution.
George A; Girault S; Testard A; Delva R; Soulié P; Couturier OF; Morel O
Nucl Med Commun; 2014 Mar; 35(3):282-90. PubMed ID: 24240193
[TBL] [Abstract][Full Text] [Related]
9. 18F-fluorodeoxyglucose positron emission tomography-computed tomography imaging in the management of Merkel cell carcinoma: a single-institution retrospective study.
Ibrahim SF; Ahronowitz I; McCalmont TH; Hernandez Pampaloni M; Ryan JL; Yu SS
Dermatol Surg; 2013 Sep; 39(9):1323-33. PubMed ID: 23777452
[TBL] [Abstract][Full Text] [Related]
10. Prospective analysis of the utility of 18-FDG PET in Merkel cell carcinoma of the skin: A Trans Tasman Radiation Oncology Group Study, TROG 09:03.
Poulsen M; Macfarlane D; Veness M; Estall V; Hruby G; Kumar M; Pullar A; Tripcony L; Rischin D
J Med Imaging Radiat Oncol; 2018 Jun; 62(3):412-419. PubMed ID: 29405630
[TBL] [Abstract][Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET/CT for Monitoring Response of Merkel Cell Carcinoma to the Novel Programmed Cell Death Ligand 1 Inhibitor Avelumab.
Eshghi N; Lundeen TF; MacKinnon L; Avery R; Kuo PH
Clin Nucl Med; 2018 May; 43(5):e142-e144. PubMed ID: 29538029
[TBL] [Abstract][Full Text] [Related]
13. Merkel cell carcinoma: two case reports focusing on the role of fluorodeoxyglucose positron emission tomography imaging in staging and surveillance.
Yao M; Smith RB; Hoffman HT; Funk GF; Graham MM; Buatti JM
Am J Clin Oncol; 2005 Apr; 28(2):205-10. PubMed ID: 15803018
[TBL] [Abstract][Full Text] [Related]
14. [Cutaneous Merkel cell carcinoma: role of 18FDG PET-CT].
Amal G; Sara T; Ghofrane CS; Malika AI; Majdouline H; Souha S; Abdelatif B; Najoua T; Ghita B; Zineb B; Nabil C
Pan Afr Med J; 2016; 23():156. PubMed ID: 27303574
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography/computed tomography imaging in Merkel cell carcinoma: a study of 270 scans in 97 patients at the Dana-Farber/Brigham and Women's Cancer Center.
Hawryluk EB; O'Regan KN; Sheehy N; Guo Y; Dorosario A; Sakellis CG; Jacene HA; Wang LC
J Am Acad Dermatol; 2013 Apr; 68(4):592-599. PubMed ID: 23127473
[TBL] [Abstract][Full Text] [Related]
16. Baseline ultrasound and FDG-PET/CT imaging in Merkel cell carcinoma.
Zijlker LP; Bakker M; van der Hiel B; Bruining A; Klop WMC; Zuur CL; Wouters MWJM; van Akkooi ACJ
J Surg Oncol; 2023 Apr; 127(5):841-847. PubMed ID: 36573839
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of
Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
[TBL] [Abstract][Full Text] [Related]
18. The impact of
Elmanzalawy A; Vali R; Chavhan GB; Gupta AA; Omarkhail Y; Amirabadi A; Shammas A
Pediatr Radiol; 2020 Feb; 50(2):252-260. PubMed ID: 31628508
[TBL] [Abstract][Full Text] [Related]
19. FDG-PET imaging in Merkel cell carcinoma - value of head-to-toe scan.
Golan H; Volkov O; Linchinsky O; Melloul M
Nucl Med Rev Cent East Eur; 2005; 8(2):135-6. PubMed ID: 16437401
[TBL] [Abstract][Full Text] [Related]
20. Whole-Body versus Routine Skull Base to Mid-thigh
Ozdemir S; McCook B; Klassen C
J Clin Imaging Sci; 2020; 10():47. PubMed ID: 32874752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
